Page not found

Search results

  1. Tech Connect, Vol. 7, Issue 7: CTTC welcomes UASP Fellow Tonny Omwansa

    ... of Nairobi. Tonny discussed innovation, entrepreneurship and technology transfer best practices with CTTC Licensing Officers and New ... Spotlight: New Drug for Blood Clot: FXII Inhibitors to Treat Thrombosis ...

    steelmk - 11/10/2016 - 7:45am

  2. Tech Connect, Vol. 6, Issue 5: PinPtr and VenoStent win the NSF Accelerating Innovation Research - Technology Translation Grant

    ... and VenoStent win the NSF Accelerating Innovation Research - Technology Translation Grant  Two Vanderbilt technologies, ... cytotoxicity of chemotherapeutic agents with multisubstrate inhibitors of histone, protein-lys, polyamine acetylation, and ...

    steelmk - 11/15/2016 - 4:18pm

  3. Zeno Power: Vanderbilt’s NSF I-Corps team makes an impact through innovation

    ... decades without needing maintenance or refueling. Ideal for use in remote, austere settings, the technology works by converting recycled nuclear waste—decaying ...

    sommers - 04/12/2021 - 10:57am

  4. Tech Connect, Vol. 7, Issue 5: New study shows Play Nicely™ program is an effective positive parenting strategy

    ... Technology Spotlight:  microRNAs Inhibition of Selected ... Advancing Translational Sciences team for small molecule inhibitors of Lactate Dehydrogenase co-developed by both institutions.  The ...

    steelmk - 11/15/2016 - 2:29pm

  5. Tech Connect, Vol. 7, Issue 6: Dates announced for Vanderbilt Pre-Flight Program

    ... Technology Spotlight: I-Wire A Biotension Measurement ... the small molecule inhibitors to Mcl-1 to 17 companies,  developed by Steve Fesik from ...

    steelmk - 11/10/2016 - 7:45am

  6. Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment

    ... The licensing agreement, facilitated by the  Center for Technology Transfer and Commercialization  and the Office of the Vice Provost ... small part thanks to the dedicated efforts of the Center for Technology Transfer and Commercialization team,” Raghavan said. “They have ... bedside, and our therapeutics a step closer to patient use.” ...

    sommers - 10/30/2020 - 12:45pm

  7. CTTC breaks records in rapid facilitation of COVID-19 related agreements

    ... to ending the global pandemic. Vanderbilt’s  Center for Technology Transfer & Commercialization  (CTTC) has accelerated its services ... A license agreement is a contract that enables an entity to use Vanderbilt’s intellectual property rights in order to further develop ...

    sommers - 07/10/2020 - 8:21am

  8. Vanderbilt-developed exosuit selected for innovation and entrepreneurship showcase in Washington, D.C.

    ... at Vanderbilt University that blends comfort, ease of use and accessibility for all and is built for maximum range of motion is being ... Bayh-Dole Act allowed us to develop this wearable assistive technology at Vanderbilt, prove out the science and then license it so HeroWear ...

    sommers - 12/08/2020 - 10:17am

  9. Vanderbilt Start up SkyNano wins 2020 R&D100 Award

    ... For the fourth year in a row, a Vanderbilt technology is taking home one of the prestigious R&D100 awards for 2020. The ... process developed by Dr. Cary Pint’s laboratory and makes use of high-value secondary material produced from greenhouse gases and relies ...

    sommers - 10/30/2020 - 12:46pm

  10. Discovery of natural compound may help fend off antibiotic resistance of hard-to-treat infections

    ...  bacteria. Bachmann is working with the  Center for Technology Transfer and Commercialization  to explore development for clinical use. Funding for this research was provided by NIH/NIAD grant 1R01AI140400, ...

    sommers - 08/19/2020 - 6:47pm